Ireland· IE-PA-PA22865/011/002

Cabergoline 2 mg Tablets

A cabergoline product containing cabergoline, registered in Ireland by Renata Pharmaceuticals (Ireland) Limited. The same ATC class is registered in 8 of our 19 countries.

ATC N04BC06

Checked against HPRA (Ireland) on September 28, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cabergolineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cabergoline is registered in 8 of 19 countries.

Countries holding a registration under ATC N04BC06 (cabergoline), each read from that country’s own register.

This record: Ireland, from HPRA (Ireland)
4 of them publish a price we can compare per daily dose

Search cabergoline products by name

Cabergoline · ATC N04BC06

8 / 19 countries

Belgiumprice
Denmark
Finlandprice
Germany
Ireland
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of cabergoline costs, country by country.

Normalised to the WHO defined daily dose (3 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Cabergoline · price per daily dose (3 mg)

USD · FX 28 Sept 2026

FR France$20.42

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)

Active substance: Cabergoline
Manufacturer: Renata Pharmaceuticals (Ireland) Limited
Country: Ireland (IE)
ATC code: N04BC06
ATC class: Cabergoline
Defined daily dose: 3 mg, O
Reimbursed: Not published by this register
Source register: HPRA (Ireland)
Last checked: September 28, 2026

Packs & prices · 1

ie_pa_number
PA22865/011/002

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

65 interactions on record for cabergoline.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cabergoline against other medicines How interaction checks work

Cabergoline · interactions on record

65 records

3 severe
17 moderate
45 info

Most severe, free to view

LorcaserinA08AA11severe
ErythromycinJ01FA01severe
ClarithromycinJ01FA09severe
MetoclopramideA03FA01moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cabergoline in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cabergoline products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Cabaseril, Dostinex
Belgium · Cabergoline Teva, Dostinex
Bulgaria · Достинекс
Cyprus · Dostinex
Czechia · Dostinex
Germany · Cabaseril, Cabergoletten
Denmark · Cabenex, Cabergolin Teva
Spain · Cabergolina Teva, Dostinex
Finland · Cabaser, Dostinex
France · Cabergoline Arrow, Cabergoline Biogaran
United Kingdom (Northern Ireland) · Cabaser, Cabergoline Aspire Pharma
Greece · Dostinex
Croatia · Dostinex
Iceland · Dostinex
Italy · Cabaser, Cabergolina Aurobindo
Luxembourg · Cabergoline Teva, Dostinex
Latvia · Dostinex
Malta · Cabergoline Aurobindo, Cabergoline Doc
Netherlands · Cabergoline Aurobindo, Cabergoline Pch
Norway · Cabergoline Renata Pharmaceuticals (Ireland), Dostinex
Poland · Dostinex
Portugal · Cabergolina Generis, Cabergoline 0.5 Mg Tablets
Romania · Dostinex
Sweden · Cabenex, Cabergoline Ratiopharm
Slovakia · Cabest

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/4c960567-12fd-46ef-9f0a-00befbc9da6c
GET /v1/drugs/4c960567-12fd-46ef-9f0a-00befbc9da6c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N04BC06"
  ],
  "strength": null,
  "pa_number": "PA22865/011/002",
  "substances": [
    "Cabergoline"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "13/10/2023",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

API reference MCP server Plans

See everything about cabergoline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console